HR
DGX icon

Howe & Rusling’s Quest Diagnostics DGX Stock Holding History

Howe & Rusling’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-550
Closed -$60K – 867
2018
Q2 		$60K Buy
550
+520
+1,733% +$54.2K 0.01% 236
2018
Q1 		$3K Buy
+30
New +$3.07K ﹤0.01% 690
2017
Q3 		– Sell
-37
Closed -$4K – 894
2017
Q2 		$4K Hold
37
– – ﹤0.01% 663
2017
Q1 		$4K Hold
37
– – ﹤0.01% 700
2016
Q4 		$3K Hold
37
– – ﹤0.01% 774
2016
Q3 		$3K Buy
+37
New +$3.11K ﹤0.01% 759
2015
Q1 		– Sell
-53
Closed -$4K – 942
2014
Q4 		$4K Hold
53
– – ﹤0.01% 641
2014
Q3 		$3K Buy
+53
New +$3.27K ﹤0.01% 685

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
FMI
Fiduciary Management Inc Milwaukee, Wisconsin $7.03B AUM 11.68% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
MWNA
Marshall Wace North America New York $23.5B AUM 46.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Bessemer Group
Bessemer Group Woodbridge, New Jersey $72.7B AUM 39.36% 1-Year Est. Return

Howe & Rusling's DGX Position: Q3 2018 in Review

Howe & Rusling sold out of Quest Diagnostics (DGX) in Q3 2018, closing a stake of 550 shares — an estimated $60K sold.

Howe & Rusling first reported a position in DGX in Q3 2014 and held it in 8 quarters. The position peaked at $60K in Q2 2018. 674 funds tracked by Wall St. Rank hold DGX as of Q3 2018.

  • Howe & Rusling reported no remaining Quest Diagnostics position as of Q3 2018 after selling out during the quarter.
  • Howe & Rusling sold 550 Quest Diagnostics shares in Q3 2018, an estimated $60K.
  • Howe & Rusling first reported a position in Quest Diagnostics in Q3 2014 and held it in 8 quarters.
  • Howe & Rusling's Quest Diagnostics position peaked at $60K in Q2 2018.
  • 674 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2018.

Based on Howe & Rusling's 13F filing for Q3 2018, filed 7 Nov 2018.